To prohibit a REMS-certified provider from prescribing mifepristone without an in-person visit and a medical license in the State in which the patient resides, and for other purposes.
119-HR-9421119th CongressIntroduced Jun 24, 2026
Market Probability
No market
Status
Introduced
Committee
Floor Vote
Other Chamber
Signed
Referred to the House Committee on Energy and Commerce.
Sponsor
Rep. Biggs, Sheri [R-SC-3](R-SC-3)5 cosponsors
Actions (3)
Referred to the House Committee on Energy and Commerce.
Jun 24, 2026House floor actions
Introduced in House
Jun 24, 2026Library of Congress
Introduced in House
Jun 24, 2026Library of Congress